Houlihan Lokey Bulks Up Healthcare Team

John Soden and Craig Cook have joined the healthcare group of Houlihan Lokey. Soden will serve as a San Francisco-based managing director, and previously was with Thomas Weisel Partners. Cook will be a London-based director in charge of European healthcare services, and previously was with Lydian Capital.

PRESS RELEASE

Houlihan Lokey, an international investment bank, announced that two veteran investment bankers have joined the firm’s Healthcare Group: John Soden, a Managing Director in the San Francisco office, and Craig Cook, a Director in the London office.

Mr. Soden, formerly a Managing Director with Thomas Weisel Partners, is leading Houlihan Lokey’s Medical Technologies practice, overseeing medical devices and products, life science tools and reagents, diagnostics and biopharmaceuticals. Mr. Cook, formerly CEO of the private equity firm Lydian Capital, is the head of Healthcare Services in Europe.

“Rapid and monumental changes in healthcare are driving the growth of our business in this industry,” said Patrick Hurst, Managing Director and Head of Houlihan Lokey’s Healthcare Group. “John and Craig are joining us at an exciting time and their expertise will be a great asset to our clients going forward.”

Houlihan Lokey’s Healthcare Group is a recognized leader in M&A advisory and capital-raising services. Its Healthcare Group is among the largest in the field, focusing on four sectors: Healthcare Services, Managed Care, Healthcare Information Technology and Medical Technologies.

Mr. Soden comes to Houlihan Lokey with more than 14 years experience in investment banking. His key deals include: the $1.1 billion sale of AB Sciex and related assets to Danaher on behalf of Life Technologies; the $780 million merger of FoxHollow Technologies with ev3; the $715 million acquisition of Laserscope by American Medical Systems; and the $273 million acquisition of Ambion by Applied Biosystems. Prior to Thomas Weisel Partners, Mr. Soden was a Director in the healthcare and M&A groups at UBS Investment Bank. He joined the predecessor firm, Dillon, Read & Co., as an Associate in 1997.

Mr. Cook joins Houlihan Lokey with more than 17 years of experience in investment banking and private equity, specializing in mergers and acquisitions. Some of his key industry deals include the $400 million acquisition of Castlebeck Holdings on behalf of Lydian Capital and the $50 million acquisition of Clinovia by Lyceum Capital. Most recently, he was the CEO of Lydian Capital, a $3 billion private equity fund focused on the U.K. and U.S. Healthcare sectors.

About Houlihan Lokey

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm is ranked globally as the No. 1 restructuring advisor, the No. 1 M&A fairness opinion advisor over the past 10 years, and the No. 1 M&A advisor for U.S. transactions under $3 billion, according to Thomson Reuters. Houlihan Lokey has 14 offices and more than 800 employees in the United States, Europe and Asia. The firm serves more than 1,000 clients each year, ranging from closely held companies to Global 500 corporations. For more information, visit www.HL.com.